SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients.
Afoke KokoghoTrevor A CrowellMuneerah M AleissaAna-Mihaela LupanSonya DaveyJun Bai Park ChangLindsey R BadenStephen R WalshAmy C ShermanPublished in: Open forum infectious diseases (2023)
Overall, most HSCT recipients had high SARS-CoV-2 antibody responses. More vaccine doses improved the magnitude of immune responses. Anti-S IgG monitoring may be useful for identifying attenuated vaccine-induced responses.